Minova Life Science

Minova life sciences - Pharmaceutical company

Lumepace-A Tablets

Malaria still a growing threat

 

COMPOSITION

Lumefentrine 80 mg + Artemether 480 mg

INDICATION

  • Uncomplicated Plasmodium falciparum malaria
  • Multi-drug resistant plasmodium falciparum malaria

 

LumepaceA

 

                                                        Provides complete protection against Malaria infection

Explore other products

Scroll to Top